Annual FCF
-$59.28 M
-$24.69 M-71.35%
December 31, 2023
Summary
- As of February 7, 2025, SCPH annual free cash flow is -$59.28 million, with the most recent change of -$24.69 million (-71.35%) on December 31, 2023.
- During the last 3 years, SCPH annual FCF has fallen by -$31.59 million (-114.08%).
- SCPH annual FCF is now -513.90% below its all-time high of -$9.66 million, reached on December 31, 2015.
Performance
SCPH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$17.43 M
+$2.79 M+13.81%
September 30, 2024
Summary
- As of February 7, 2025, SCPH quarterly free cash flow is -$17.43 million, with the most recent change of +$2.79 million (+13.81%) on September 30, 2024.
- Over the past year, SCPH quarterly FCF has dropped by -$2.24 million (-14.73%).
- SCPH quarterly FCF is now -345.74% below its all-time high of -$3.91 million, reached on June 30, 2019.
Performance
SCPH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$70.56 M
-$3.98 M-5.98%
September 30, 2024
Summary
- As of February 7, 2025, SCPH TTM free cash flow is -$70.56 million, with the most recent change of -$3.98 million (-5.98%) on September 30, 2024.
- Over the past year, SCPH TTM FCF has dropped by -$11.27 million (-19.01%).
- SCPH TTM FCF is now -1387.58% below its all-time high of -$4.74 million, reached on March 31, 2017.
Performance
SCPH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SCPH Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -71.3% | -14.7% | -19.0% |
| 3 y3 years | -114.1% | -47.3% | -103.9% |
| 5 y5 years | -105.8% | -47.3% | -103.9% |
SCPH Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.3% | at low | -145.6% | +13.8% | -172.2% | at low |
| 5 y | 5-year | -118.3% | at low | -262.6% | +13.8% | -172.2% | at low |
| alltime | all time | -513.9% | at low | -345.7% | +13.8% | -1387.6% | at low |
ScPharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.43 M(-13.8%) | -$70.56 M(+6.0%) |
| Jun 2024 | - | -$20.23 M(+14.3%) | -$66.57 M(+10.1%) |
| Mar 2024 | - | -$17.70 M(+16.5%) | -$60.49 M(+2.0%) |
| Dec 2023 | -$59.28 M(+71.4%) | -$15.20 M(+13.0%) | -$59.28 M(+6.0%) |
| Sep 2023 | - | -$13.45 M(-4.9%) | -$55.93 M(+10.3%) |
| Jun 2023 | - | -$14.14 M(-14.2%) | -$50.69 M(+15.9%) |
| Mar 2023 | - | -$16.49 M(+39.3%) | -$43.72 M(+26.4%) |
| Dec 2022 | -$34.60 M(+27.4%) | -$11.84 M(+44.2%) | -$34.60 M(+15.9%) |
| Sep 2022 | - | -$8.21 M(+14.4%) | -$29.86 M(+11.3%) |
| Jun 2022 | - | -$7.17 M(-2.7%) | -$26.82 M(+3.5%) |
| Mar 2022 | - | -$7.38 M(+3.9%) | -$25.92 M(-4.6%) |
| Dec 2021 | -$27.16 M(-1.9%) | -$7.10 M(+37.1%) | -$27.16 M(-7.1%) |
| Sep 2021 | - | -$5.18 M(-17.4%) | -$29.24 M(+1.3%) |
| Jun 2021 | - | -$6.27 M(-27.2%) | -$28.87 M(+1.1%) |
| Mar 2021 | - | -$8.62 M(-6.2%) | -$28.57 M(+3.1%) |
| Dec 2020 | -$27.69 M | -$9.18 M(+90.9%) | -$27.69 M(-17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$4.81 M(-19.4%) | -$33.35 M(-2.3%) |
| Jun 2020 | - | -$5.96 M(-23.0%) | -$34.12 M(+6.4%) |
| Mar 2020 | - | -$7.74 M(-47.8%) | -$32.07 M(+5.3%) |
| Dec 2019 | -$30.44 M(+5.7%) | -$14.84 M(+166.0%) | -$30.44 M(+42.5%) |
| Sep 2019 | - | -$5.58 M(+42.6%) | -$21.37 M(+0.5%) |
| Jun 2019 | - | -$3.91 M(-36.1%) | -$21.25 M(-17.8%) |
| Mar 2019 | - | -$6.12 M(+6.2%) | -$25.86 M(-10.3%) |
| Dec 2018 | -$28.81 M(+25.9%) | -$5.76 M(+5.4%) | -$28.81 M(-0.6%) |
| Sep 2018 | - | -$5.46 M(-35.8%) | -$29.00 M(-2.0%) |
| Jun 2018 | - | -$8.51 M(-6.2%) | -$29.59 M(+8.8%) |
| Mar 2018 | - | -$9.07 M(+52.6%) | -$27.21 M(+18.9%) |
| Dec 2017 | -$22.88 M(+47.9%) | -$5.95 M(-1.9%) | -$22.88 M(+35.1%) |
| Sep 2017 | - | -$6.06 M(-1.0%) | -$16.93 M(+55.8%) |
| Jun 2017 | - | -$6.13 M(+29.2%) | -$10.87 M(+129.2%) |
| Mar 2017 | - | -$4.74 M | -$4.74 M |
| Dec 2016 | -$15.46 M(+60.1%) | - | - |
| Dec 2015 | -$9.66 M | - | - |
FAQ
- What is scPharmaceuticals annual free cash flow?
- What is the all time high annual FCF for scPharmaceuticals?
- What is scPharmaceuticals annual FCF year-on-year change?
- What is scPharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for scPharmaceuticals?
- What is scPharmaceuticals quarterly FCF year-on-year change?
- What is scPharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for scPharmaceuticals?
- What is scPharmaceuticals TTM FCF year-on-year change?
What is scPharmaceuticals annual free cash flow?
The current annual FCF of SCPH is -$59.28 M
What is the all time high annual FCF for scPharmaceuticals?
scPharmaceuticals all-time high annual free cash flow is -$9.66 M
What is scPharmaceuticals annual FCF year-on-year change?
Over the past year, SCPH annual free cash flow has changed by -$24.69 M (-71.35%)
What is scPharmaceuticals quarterly free cash flow?
The current quarterly FCF of SCPH is -$17.43 M
What is the all time high quarterly FCF for scPharmaceuticals?
scPharmaceuticals all-time high quarterly free cash flow is -$3.91 M
What is scPharmaceuticals quarterly FCF year-on-year change?
Over the past year, SCPH quarterly free cash flow has changed by -$2.24 M (-14.73%)
What is scPharmaceuticals TTM free cash flow?
The current TTM FCF of SCPH is -$70.56 M
What is the all time high TTM FCF for scPharmaceuticals?
scPharmaceuticals all-time high TTM free cash flow is -$4.74 M
What is scPharmaceuticals TTM FCF year-on-year change?
Over the past year, SCPH TTM free cash flow has changed by -$11.27 M (-19.01%)